Delivery Order SPE2DB25D3006-SPE2DB25FXJNP
- Not listed
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,401.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on June 3, 2025, with an ultimate completion date of June 4, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract carries a ceiling value of $2,069.39 and is structured as a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,468.28 to supply Zepbound 7.5 mg/0.5 mL pen injections on June 2, 2025, with completion targeted for June 3, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXJNPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves critical federal medical procurement needs through open competition. The company's extensive federal contract portfolio with the DLA Medical Supply Chain encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. The Zepbound delivery order supports the Defense Logistics Agency's medical supply operations, which ultimately serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems requiring reliable pharmaceutical commodities for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 6/17/25 |